Novartis Investigative Site
				
				Port Royal, South Carolina 29935
We've found
        1 trials
        at this facility
      	
	Relapsing Multiple Sclerosis Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	